Roger M. Nitsch

Neurimmune

Roger M. Nitsch is listed as Neurimmune. Roger is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 16 March 2027.

Compiled from published conference agendas; not yet confirmed by Roger. Is this you? Claim this profile.

About

Roger M. Nitsch serves as CEO & President of Neurimmune, which he founded in 2006 together with Jan Grimm and Christoph Hock. A neuroscientist with a background in medicine, Roger is recognized as an opinion leader in neurodegenerative diseases with over 30 years of experience in biotech and as a pioneer in the development of therapeutic approaches for protein aggregation diseases. A Potamkin Prize winner, Member of the German Academy of Sciences and Professor Emeritus at University of Zurich, Roger served as a founding director of the Institute for Regenerative Medicine, University of Zurich.

Upcoming

AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027

GLOBAL LEADERSHIP FORUM: MOONSHOTS & MILESTONES: WHO WILL OWN THE FUTURE OF NEURODEGENERATION? Moderator · 16 March 2027
PLENARY LECTURE 3, 4 Moderator · 17 March 2027